Ingolf Mølle
Impact in
-
- Amoebic Infections and Treatments
- Tuberculosis Research and Epidemiology
- COVID-19 Clinical Research Studies
-
- Multiple Myeloma Research and Treatments
Papers in
-
- Amoebic Infections and Treatments 2
- COVID-19 Clinical Research Studies 1
-
- Multiple Myeloma Research and Treatments 3
- Co-authors
- Henrik Toft Sørensen (3 shared papers)Niels Anker Peterslund (4 shared papers)Steffen Thiel (3 shared papers)A.M. Thulstrup (1 shared paper)Rudi Steffensen (3 shared papers)Hans‐Christian Slotved (1 shared paper)Helene Andrea Sinclair Ingels (1 shared paper)Maja Hinge (1 shared paper)
- Journals
- European Journal Of Haematology (4 papers)British Journal of Haematology (2 papers)Apmis (2 papers)Blood Advances (2 papers)Blood (1 paper)
- Partner nations
- DenmarkUnited StatesSweden
In The Last Decade
Ingolf Mølle
21 papers receiving 297 citations
Peers
Comparison fields: 5 of 41
- Infectious Diseases 93
- Hematology 47
- Hepatology 30
- Immunology 56
- Oncology 51
Countries citing papers authored by Ingolf Mølle
This map shows the geographic impact of Ingolf Mølle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingolf Mølle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingolf Mølle more than expected).
Fields of papers citing papers by Ingolf Mølle
This network shows the impact of papers produced by Ingolf Mølle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingolf Mølle. The network helps show where Ingolf Mølle may publish in the future.
Co-authors
The 25 scholars most cited alongside Ingolf Mølle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 50 | |
| 2 | 2001 | 47 | |
| 3 | 2006 | 31 | |
| 4 | 2012 | 30 | |
| 5 | 2006 | 25 | |
| 6 | 2020 | 23 | |
| 7 | 2010 | 22 | |
| 8 | 2012 | 18 | |
| 9 | 2006 | 11 | |
| 10 | 2008 | 10 | |
| 11 | 2018 | 8 | |
| 12 | 2022 | 7 | |
| 13 | 2001 | 5 | |
| 14 | 2019 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2011 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2022 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2006 | 1 |
About Ingolf Mølle
Ingolf Mølle is a scholar working on Infectious Diseases, Hematology, Immunology, Public Health, Environmental and Occupational Health and Oncology, having authored 22 papers that have together received 311 indexed citations. Recurring topics across this work include Complement system in diseases (3 papers), Multiple Myeloma Research and Treatments (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Amoebic Infections and Treatments (2 papers), Retinoids in leukemia and cellular processes (2 papers), Neutropenia and Cancer Infections (2 papers), Cancer Immunotherapy and Biomarkers (1 paper) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Infectious Diseases (93 citations), Hematology (47 citations), Hepatology (30 citations), Immunology (56 citations) and Oncology (51 citations). Ingolf Mølle has collaborated with scholars based in Denmark, United States and Sweden. Frequent co-authors include Henrik Toft Sørensen, Niels Anker Peterslund, Steffen Thiel, A.M. Thulstrup, Rudi Steffensen, Hans‐Christian Slotved, Helene Andrea Sinclair Ingels, Maja Hinge, R. Steffensen and Jens Kjølseth Møller. Their work appears in journals such as European Journal Of Haematology, British Journal of Haematology, Apmis, Blood Advances and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.